Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

This study has been completed.
Baxter Healthcare Corporation
Information provided by (Responsible Party):
Theresa Zesiewicz, University of South Florida Identifier:
First received: April 20, 2011
Last updated: July 19, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)